FDA inspection
Division of Nuclear Medicine PET Radiopharmaceutical Production Program: FDA inspection ending Mar 7, 2019
FDA inspection 1082112 · Voluntary Action Indicated (VAI) · Ann Arbor, MI
Key facts
| Inspection ID | 1082112 |
|---|---|
| Firm | Division of Nuclear Medicine PET Radiopharmaceutical Production Program |
| FEI number | 3010166888 |
| Address | 1301 Catherine St, 2276 Medical Science Bldg 1, Spc-5610 |
| City | Ann Arbor |
| State | MI |
| ZIP | 48109 |
| Country | United States |
| Fiscal year | 2019 |
| Inspection end date | Mar 7, 2019 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data